Literature DB >> 1971735

Identification of a putative cell receptor for human cytomegalovirus.

J D Adlish1, R S Lahijani, S C St Jeor.   

Abstract

Proteins from a variety of cell types were separated using SDS-PAGE, transferred to nitrocellulose filters, and probed with intact human cytomegalovirus (HCMV). Virus bound to cell proteins was detected directly using 125I-labeled HCMV or indirectly using an immunologic assay with a secondary antibody labeled with 125I. Using this approach proteins of molecular weights 32 and 34 kDa were identified that would bind HCMV and were present on T4+ and T8+ lymphocytes, a B lymphoblastoid cell line, and human diploid fibroblasts. Binding of labeled virus to cells could be blocked by the addition of unlabeled homologous virus. Treatment of virus with NP40 to remove the virus envelope blocked binding to cellular proteins. Both the 32- and 34-kDa proteins could be copurified with cellular membranes. HCMV bound equally well to T4+ and T8+ cells as well as to either replicating (PHA or interleukin-2 stimulated) or resting lymphocytes. Interestingly, there appeared to be a single binding site for HCMV on human fibroblasts (34 kDa). The results support the idea that there is a receptor for HCMV present on the surface of human lymphocytes and fibroblasts.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 1971735     DOI: 10.1016/0042-6822(90)90003-a

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  20 in total

1.  Interaction of recombinant norwalk virus particles with the 105-kilodalton cellular binding protein, a candidate receptor molecule for virus attachment.

Authors:  M Tamura; K Natori; M Kobayashi; T Miyamura; N Takeda
Journal:  J Virol       Date:  2000-12       Impact factor: 5.103

2.  The human fibroblast receptor for gp86 of human cytomegalovirus is a phosphorylated glycoprotein.

Authors:  S Keay; B Baldwin
Journal:  J Virol       Date:  1992-08       Impact factor: 5.103

3.  Direct interaction between human cytomegalovirus glycoprotein B and cellular annexin II.

Authors:  R L Pietropaolo; T Compton
Journal:  J Virol       Date:  1997-12       Impact factor: 5.103

4.  Host cellular annexin II is associated with cytomegalovirus particles isolated from cultured human fibroblasts.

Authors:  J F Wright; A Kurosky; E L Pryzdial; S Wasi
Journal:  J Virol       Date:  1995-08       Impact factor: 5.103

5.  Definition of a subset of human peripheral blood mononuclear cells that are permissive to human cytomegalovirus infection.

Authors:  C Söderberg; S Larsson; S Bergstedt-Lindqvist; E Möller
Journal:  J Virol       Date:  1993-06       Impact factor: 5.103

6.  Transcriptional activation of cellular oncogenes fos, jun, and myc by human cytomegalovirus.

Authors:  I Boldogh; S AbuBakar; C Z Deng; T Albrecht
Journal:  J Virol       Date:  1991-03       Impact factor: 5.103

7.  CD13 (human aminopeptidase N) mediates human cytomegalovirus infection.

Authors:  C Söderberg; T D Giugni; J A Zaia; S Larsson; J M Wahlberg; E Möller
Journal:  J Virol       Date:  1993-11       Impact factor: 5.103

8.  Characterization of lymphocytic choriomeningitis virus-binding protein(s): a candidate cellular receptor for the virus.

Authors:  P Borrow; M B Oldstone
Journal:  J Virol       Date:  1992-12       Impact factor: 5.103

9.  Evidence that neomycin inhibits human cytomegalovirus infection of fibroblasts.

Authors:  P E Lobert; D Hober; A S Delannoy; P Wattré
Journal:  Arch Virol       Date:  1996       Impact factor: 2.574

10.  Anti-idiotype antibodies that mimic gp86 of human cytomegalovirus inhibit viral fusion but not attachment.

Authors:  S Keay; B Baldwin
Journal:  J Virol       Date:  1991-09       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.